Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 1,601–1,650 of 1,705 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06172036	Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab(CAPT-02)	not yet recruiting	Phase 2	180	Zhejiang UniversityOTHER	0	Dec 15, 2023	clinicaltrials
NCT06121271	Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications	not yet recruiting	Phase 2	110	University College, LondonOTHER	0	Dec 7, 2023	clinicaltrials